Chlorine in PDB 6hgm: Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy
Protein crystallography data
The structure of Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy, PDB code: 6hgm
was solved by
K.Schmidt,
Y.A.Muller,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
38.67 /
1.37
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
71.338,
77.341,
79.283,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
16.8 /
18.1
|
Other elements in 6hgm:
The structure of Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy also contains other interesting chemical elements:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy
(pdb code 6hgm). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 3 binding sites of Chlorine where determined in the
Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy, PDB code: 6hgm:
Jump to Chlorine binding site number:
1;
2;
3;
Chlorine binding site 1 out
of 3 in 6hgm
Go back to
Chlorine Binding Sites List in 6hgm
Chlorine binding site 1 out
of 3 in the Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl401
b:16.7
occ:1.00
|
HE
|
A:ARG349
|
2.3
|
22.2
|
1.0
|
HG
|
B:SER392
|
2.4
|
20.7
|
1.0
|
HH21
|
A:ARG349
|
2.5
|
29.3
|
1.0
|
NE
|
A:ARG349
|
3.1
|
18.5
|
1.0
|
HA
|
B:MET391
|
3.1
|
12.1
|
1.0
|
OG
|
B:SER392
|
3.2
|
17.2
|
1.0
|
HB3
|
B:PHE390
|
3.2
|
16.9
|
1.0
|
NH2
|
A:ARG349
|
3.2
|
24.4
|
1.0
|
HG12
|
B:ILE380
|
3.3
|
21.3
|
1.0
|
HB2
|
B:MET378
|
3.3
|
16.1
|
1.0
|
HB2
|
B:PHE390
|
3.5
|
16.9
|
1.0
|
HB3
|
B:SER392
|
3.5
|
15.3
|
1.0
|
H
|
B:SER392
|
3.6
|
12.7
|
1.0
|
CZ
|
A:ARG349
|
3.6
|
22.6
|
1.0
|
N
|
B:SER392
|
3.6
|
10.6
|
1.0
|
CA
|
B:MET391
|
3.6
|
10.1
|
1.0
|
C
|
B:MET391
|
3.6
|
9.7
|
1.0
|
HB3
|
B:MET378
|
3.7
|
16.1
|
1.0
|
N
|
B:MET391
|
3.7
|
9.8
|
1.0
|
O
|
B:MET378
|
3.7
|
10.1
|
1.0
|
CB
|
B:PHE390
|
3.8
|
14.1
|
1.0
|
C
|
B:PHE390
|
3.8
|
10.6
|
1.0
|
CB
|
B:SER392
|
3.8
|
12.7
|
1.0
|
HD13
|
A:ILE51
|
3.9
|
19.0
|
1.0
|
CB
|
B:MET378
|
3.9
|
13.4
|
1.0
|
O
|
B:PHE390
|
3.9
|
12.1
|
1.0
|
HH22
|
A:ARG349
|
3.9
|
29.3
|
1.0
|
HE3
|
B:MET378
|
3.9
|
18.8
|
1.0
|
HD12
|
A:ILE51
|
4.0
|
19.0
|
1.0
|
C
|
B:MET378
|
4.0
|
12.3
|
1.0
|
H
|
B:MET391
|
4.0
|
11.8
|
1.0
|
HD3
|
A:ARG349
|
4.1
|
22.6
|
1.0
|
HA
|
B:ILE379
|
4.1
|
14.1
|
1.0
|
H
|
B:ILE380
|
4.2
|
16.2
|
1.0
|
CG1
|
B:ILE380
|
4.2
|
17.8
|
1.0
|
HD13
|
A:LEU340
|
4.2
|
19.8
|
1.0
|
CD
|
A:ARG349
|
4.2
|
18.8
|
1.0
|
CD1
|
A:ILE51
|
4.2
|
15.8
|
1.0
|
HD22
|
A:LEU340
|
4.2
|
22.7
|
1.0
|
HD11
|
A:ILE51
|
4.2
|
19.0
|
1.0
|
O
|
B:MET391
|
4.3
|
10.3
|
1.0
|
CA
|
B:SER392
|
4.3
|
10.6
|
1.0
|
HG13
|
B:ILE380
|
4.4
|
21.3
|
1.0
|
CA
|
B:PHE390
|
4.5
|
12.3
|
1.0
|
N
|
B:ILE379
|
4.5
|
11.6
|
1.0
|
N
|
B:ILE380
|
4.6
|
13.5
|
1.0
|
CA
|
B:MET378
|
4.6
|
10.6
|
1.0
|
CA
|
B:ILE379
|
4.7
|
11.7
|
1.0
|
HB2
|
B:SER392
|
4.7
|
15.3
|
1.0
|
HG2
|
A:ARG349
|
4.7
|
18.8
|
1.0
|
HD11
|
B:ILE380
|
4.7
|
23.2
|
1.0
|
CE
|
B:MET378
|
4.9
|
15.6
|
1.0
|
HD2
|
A:ARG349
|
4.9
|
22.6
|
1.0
|
HB
|
B:ILE380
|
4.9
|
18.6
|
1.0
|
NH1
|
A:ARG349
|
4.9
|
28.7
|
1.0
|
C
|
B:ILE379
|
4.9
|
14.5
|
1.0
|
CD1
|
B:ILE380
|
4.9
|
19.4
|
1.0
|
HD13
|
B:ILE380
|
4.9
|
23.2
|
1.0
|
HA
|
B:SER392
|
5.0
|
12.7
|
1.0
|
H
|
B:MET378
|
5.0
|
10.8
|
1.0
|
CG
|
B:PHE390
|
5.0
|
15.1
|
1.0
|
HD11
|
A:LEU340
|
5.0
|
19.8
|
1.0
|
|
Chlorine binding site 2 out
of 3 in 6hgm
Go back to
Chlorine Binding Sites List in 6hgm
Chlorine binding site 2 out
of 3 in the Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl402
b:21.6
occ:1.00
|
HZ1
|
A:LYS356
|
2.2
|
26.6
|
1.0
|
H
|
A:LYS174
|
2.3
|
23.5
|
1.0
|
H
|
A:ASP175
|
2.8
|
25.0
|
1.0
|
O
|
A:HOH785
|
3.0
|
40.6
|
1.0
|
HG11
|
A:VAL335
|
3.1
|
17.9
|
1.0
|
HA
|
A:ILE173
|
3.1
|
18.4
|
1.0
|
NZ
|
A:LYS356
|
3.1
|
22.2
|
1.0
|
N
|
A:LYS174
|
3.1
|
19.6
|
1.0
|
HB2
|
A:LYS174
|
3.3
|
24.8
|
1.0
|
HZ2
|
A:LYS356
|
3.4
|
26.6
|
1.0
|
HG2
|
A:LYS174
|
3.4
|
41.6
|
1.0
|
HZ3
|
A:LYS356
|
3.6
|
26.6
|
1.0
|
N
|
A:ASP175
|
3.6
|
20.8
|
1.0
|
HG23
|
A:ILE173
|
3.6
|
26.3
|
1.0
|
HG21
|
A:VAL335
|
3.7
|
16.4
|
1.0
|
HE3
|
A:LYS356
|
3.7
|
30.4
|
1.0
|
O
|
A:ASP175
|
3.7
|
20.1
|
1.0
|
CB
|
A:LYS174
|
3.8
|
20.6
|
1.0
|
CE
|
A:LYS356
|
3.8
|
25.3
|
1.0
|
CA
|
A:ILE173
|
3.9
|
15.3
|
1.0
|
CA
|
A:LYS174
|
3.9
|
18.7
|
1.0
|
HE2
|
A:LYS356
|
3.9
|
30.4
|
1.0
|
C
|
A:ILE173
|
4.0
|
18.3
|
1.0
|
CG
|
A:LYS174
|
4.0
|
34.6
|
1.0
|
CG1
|
A:VAL335
|
4.0
|
14.9
|
1.0
|
O
|
A:LEU172
|
4.1
|
18.4
|
1.0
|
HD13
|
A:ILE173
|
4.2
|
26.0
|
1.0
|
OE1
|
A:GLN333
|
4.2
|
25.1
|
1.0
|
HG3
|
A:LYS174
|
4.3
|
41.6
|
1.0
|
C
|
A:LYS174
|
4.3
|
22.8
|
1.0
|
CG2
|
A:ILE173
|
4.4
|
21.9
|
1.0
|
HE22
|
A:GLN333
|
4.4
|
48.9
|
1.0
|
HG22
|
A:ILE173
|
4.4
|
26.3
|
1.0
|
HG13
|
A:VAL335
|
4.4
|
17.9
|
1.0
|
HB2
|
A:ASP175
|
4.4
|
39.7
|
1.0
|
CG2
|
A:VAL335
|
4.5
|
13.7
|
1.0
|
HG12
|
A:VAL335
|
4.6
|
17.9
|
1.0
|
C
|
A:ASP175
|
4.6
|
24.0
|
1.0
|
CA
|
A:ASP175
|
4.6
|
26.0
|
1.0
|
HB
|
A:VAL335
|
4.7
|
15.1
|
1.0
|
CB
|
A:VAL335
|
4.7
|
12.6
|
1.0
|
HB3
|
A:LYS174
|
4.7
|
24.8
|
1.0
|
CB
|
A:ILE173
|
4.8
|
15.9
|
1.0
|
HA
|
A:LYS174
|
4.8
|
22.4
|
1.0
|
HD12
|
A:ILE173
|
4.8
|
26.0
|
1.0
|
CD
|
A:GLN333
|
4.8
|
39.1
|
1.0
|
NE2
|
A:GLN333
|
4.9
|
40.7
|
1.0
|
N
|
A:ILE173
|
4.9
|
17.7
|
1.0
|
CD1
|
A:ILE173
|
4.9
|
21.6
|
1.0
|
C
|
A:LEU172
|
4.9
|
18.4
|
1.0
|
HG22
|
A:VAL335
|
4.9
|
16.4
|
1.0
|
|
Chlorine binding site 3 out
of 3 in 6hgm
Go back to
Chlorine Binding Sites List in 6hgm
Chlorine binding site 3 out
of 3 in the Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 3 of Crystal Structure of ALPHA1-Antichymotrypsin Variant Newbg-III-Allo: An Allosterically Controlled New Binding Globulin with An Unprecedentedly High Ligand Release Efficacy within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl403
b:15.8
occ:1.00
|
HZ3
|
A:LYS260
|
2.5
|
23.7
|
1.0
|
HD3
|
A:LYS260
|
3.2
|
18.9
|
1.0
|
NZ
|
A:LYS260
|
3.2
|
19.7
|
1.0
|
HE2
|
A:LYS260
|
3.3
|
18.2
|
1.0
|
HZ1
|
A:LYS260
|
3.6
|
23.7
|
1.0
|
HG
|
A:SER237
|
3.6
|
19.1
|
1.0
|
CE
|
A:LYS260
|
3.6
|
15.2
|
1.0
|
OG
|
A:SER237
|
3.6
|
15.9
|
1.0
|
O
|
A:HOH616
|
3.7
|
19.2
|
1.0
|
CD
|
A:LYS260
|
3.9
|
15.8
|
1.0
|
HZ2
|
A:LYS260
|
3.9
|
23.7
|
1.0
|
HG3
|
A:LYS260
|
4.3
|
16.4
|
1.0
|
H22
|
A:EDO407
|
4.4
|
36.4
|
1.0
|
HE3
|
A:LYS260
|
4.5
|
18.2
|
1.0
|
O
|
A:HOH605
|
4.6
|
22.6
|
1.0
|
HD2
|
A:LYS260
|
4.6
|
18.9
|
1.0
|
HB3
|
A:SER237
|
4.6
|
18.3
|
1.0
|
CG
|
A:LYS260
|
4.7
|
13.6
|
1.0
|
CB
|
A:SER237
|
4.7
|
15.2
|
1.0
|
CA
|
A:CA405
|
4.7
|
15.8
|
1.0
|
HB2
|
A:SER237
|
4.9
|
18.3
|
1.0
|
|
Reference:
B.R.Gardill,
K.Schmidt,
Y.A.Muller.
Newbg: A Surrogate Corticosteroid-Binding Globulin with An Unprecedentedly High Ligand Release Efficacy. J.Struct.Biol. V. 207 169 2019.
ISSN: ESSN 1095-8657
PubMed: 31103428
DOI: 10.1016/J.JSB.2019.05.006
Page generated: Sun Jul 28 00:48:14 2024
|